JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Couteur, D. G.
Right arrow Articles by McLean, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Couteur, D. G.
Right arrow Articles by McLean, A. J.

Vol. 289, Issue 3, 1553-1558, June 1999

Hepatic Artery Flow and Propranolol Metabolism in Perfused Cirrhotic Rat Liver1

David G. Le Couteur , Haruyo Hickey, Peta J. Harvey, Jill Gready and Allan J. McLean

Canberra Clinical School of the Sydney University, The Canberra Hospital, Canberra, Australia (D.G.LeC., H.H., A.J.McL.); and The John Curtin School for Medical Research, Australian National University, Canberra, Australia (D.G.LeC., P.J.H., J.G., A.J.McL.)

The oxygen limitation theory states that capillarization of the sinusoidal endothelium in cirrhosis impairs hepatocellular oxygen uptake manifesting as a reduction in oxygen-dependent enzyme activity including phase 1 drug metabolism. The hepatic artery supplies highly oxygenated blood to the liver. Therefore, we tested whether augmentation of hepatic arterial blood flow could improve hepatic oxygenation and function in cirrhosis. Rats were treated with carbon tetrachloride and phenobarbitone to induce hepatic cirrhosis or fibrosis. We used a bivascular rat liver perfusion model to examine the effects of increased hepatic artery flow on propranolol clearance and oxygen consumption. Each liver was perfused at three hepatic artery flow rates, 1 to 3, 4 to 6, and 7 to 9 ml/min with a constant portal venous flow of 7 to 9 ml/min. Increasing the hepatic artery flow led to improvement in propranolol clearance in control (n = 7, P < .001), fibrotic (n = 8, P < .001), and cirrhotic (n = 6, P < .001) livers. Intrinsic clearance of propranolol increased only in the cirrhotic livers (P = .01), indicating an improvement in enzyme activity. Regression analysis indicated that this improvement was mediated by change in oxygen delivery alone (P = .001). The results confirm that propranolol metabolizing enzyme activity in cirrhosis can be improved by increasing oxygen delivery by increasing hepatic arterial blood flow. These findings suggest that increasing hepatic arterial blood flow may be an important therapeutic strategy for improving global liver function in cirrhosis.


0022-3565/99/2893-1553$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. D. DeLeve, X. Wang, L. Hu, M. K. McCuskey, and R. S. McCuskey
Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation
Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G757 - G763.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. S. L. Cho, A. J. McLean, L. P. Rivory, P. A. Gatenby, D. T. A. Hardman, and D. G. Le Couteur
Carbon monoxide wash-in method to determine gas transfer in vascular beds: application to rat hindlimb
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1802 - H1806.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Richter, I. Mucke, M. D. Menger, and B. Vollmar
Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response
Am J Physiol Gastrointest Liver Physiol, August 1, 2000; 279(2): G454 - G462.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. J. Harvey, J. E. Gready, Z. Yin, D. G. Le Couteur, and A. J. McLean
Acute Oxygen Supplementation Restores Markers of Hepatocyte Energy Status and Hypoxia in Cirrhotic Rats
J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 641 - 645.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.